Announcement on behalf of major subsidiary,TOP PHARM.MEDICALWARE COMPANY LIMITED,regarding BOD resolved to convene the 2025 Annual General Shareholders' Meeting
To announce the expected date of the board of directors meeting to approve the consolidated financial statements is 2025/2/21 for the fourth quarter of 2024
Announcement on behalf of major subsidiary,CHUANG YI BIOTECH CO.,LTD.,regarding acquisition of right-of-use asset from related party(Update of lease agreement)